Ignite Creation Date:
2025-12-24 @ 4:44 PM
Ignite Modification Date:
2025-12-29 @ 4:35 PM
Study NCT ID:
NCT04562766
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-02-10
First Post:
2020-09-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)
Sponsor:
Principia Biopharma, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-14
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-08-26
Completion Date Type:
ESTIMATED
First Submit Date:
2020-09-18
First Submit QC Date:
None
Study First Post Date:
2020-09-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-07
Last Update Post Date:
2025-02-10
Last Update Post Date Type:
ACTUAL